These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 21646028)
21. Liver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunity. Kidani Y; Bensinger SJ Immunol Rev; 2012 Sep; 249(1):72-83. PubMed ID: 22889216 [TBL] [Abstract][Full Text] [Related]
22. Retinoid x receptor heterodimers in the metabolic syndrome. Shulman AI; Mangelsdorf DJ N Engl J Med; 2005 Aug; 353(6):604-15. PubMed ID: 16093469 [No Abstract] [Full Text] [Related]
23. Nuclear receptors and the control of metabolism. Francis GA; Fayard E; Picard F; Auwerx J Annu Rev Physiol; 2003; 65():261-311. PubMed ID: 12518001 [TBL] [Abstract][Full Text] [Related]
24. Transcriptional and posttranscriptional control of cholesterol homeostasis by liver X receptors. Tontonoz P Cold Spring Harb Symp Quant Biol; 2011; 76():129-37. PubMed ID: 21859674 [TBL] [Abstract][Full Text] [Related]
25. Stress- (and diet-) related regulation of hepatic nuclear receptors and its relevance for ABC-transporter functions. Stienstra R; Lichtenauer-Kaligis E; Müller M Drug Metab Rev; 2004 May; 36(2):391-406. PubMed ID: 15237861 [TBL] [Abstract][Full Text] [Related]
26. The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: From physiology to pathology. Kiss M; Czimmerer Z; Nagy L J Allergy Clin Immunol; 2013 Aug; 132(2):264-86. PubMed ID: 23905916 [TBL] [Abstract][Full Text] [Related]
27. PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells. Rogue A; Anthérieu S; Vluggens A; Umbdenstock T; Claude N; de la Moureyre-Spire C; Weaver RJ; Guillouzo A Toxicol Appl Pharmacol; 2014 Apr; 276(1):73-81. PubMed ID: 24534255 [TBL] [Abstract][Full Text] [Related]
28. Liver receptor homolog 1 is a negative regulator of the hepatic acute-phase response. Venteclef N; Smith JC; Goodwin B; Delerive P Mol Cell Biol; 2006 Sep; 26(18):6799-807. PubMed ID: 16943422 [TBL] [Abstract][Full Text] [Related]
29. Role of Class II nuclear receptors in liver carcinogenesis. Li G; Guo GL Anticancer Agents Med Chem; 2011 Jul; 11(6):529-42. PubMed ID: 21554208 [TBL] [Abstract][Full Text] [Related]
30. Effect of niacin on LXRalpha and PPARgamma expression and HDL-induced cholesterol efflux in adipocytes of hypercholesterolemic rabbits. Zhao SP; Yang J; Li J; Dong SZ; Wu ZH Int J Cardiol; 2008 Feb; 124(2):172-8. PubMed ID: 17395297 [TBL] [Abstract][Full Text] [Related]
31. Emerging roles for LXRs and LRH-1 in female reproduction. Mouzat K; Baron S; Marceau G; Caira F; Sapin V; Volle DH; Lumbroso S; Lobaccaro JM Mol Cell Endocrinol; 2013 Apr; 368(1-2):47-58. PubMed ID: 22750099 [TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of the liver X receptors. Chen M; Bradley MN; Beaven SW; Tontonoz P FEBS Lett; 2006 Sep; 580(20):4835-41. PubMed ID: 16904112 [TBL] [Abstract][Full Text] [Related]
33. Oxysterol signaling links cholesterol metabolism and inflammation via the liver X receptor in macrophages. Töröcsik D; Szanto A; Nagy L Mol Aspects Med; 2009 Jun; 30(3):134-52. PubMed ID: 19248804 [TBL] [Abstract][Full Text] [Related]
34. Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Laffitte BA; Chao LC; Li J; Walczak R; Hummasti S; Joseph SB; Castrillo A; Wilpitz DC; Mangelsdorf DJ; Collins JL; Saez E; Tontonoz P Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5419-24. PubMed ID: 12697904 [TBL] [Abstract][Full Text] [Related]
35. PPARs at the crossroads of lipid signaling and inflammation. Wahli W; Michalik L Trends Endocrinol Metab; 2012 Jul; 23(7):351-63. PubMed ID: 22704720 [TBL] [Abstract][Full Text] [Related]
37. Alterations in immune response and PPAR/LXR regulation in cystic fibrosis macrophages. Andersson C; Zaman MM; Jones AB; Freedman SD J Cyst Fibros; 2008 Jan; 7(1):68-78. PubMed ID: 17889625 [TBL] [Abstract][Full Text] [Related]
38. Importance of blood cellular genomic profile in coronary heart disease. Baba MI; Kaul D; Grover A J Biomed Sci; 2006 Jan; 13(1):17-26. PubMed ID: 16252156 [TBL] [Abstract][Full Text] [Related]
39. [Recent advances on liver X receptors]. Wang Q; Jiang Y Sheng Li Ke Xue Jin Zhan; 2009 Apr; 40(2):147-50. PubMed ID: 19558144 [TBL] [Abstract][Full Text] [Related]
40. Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis. Fiévet C; Staels B Biochem Pharmacol; 2009 Apr; 77(8):1316-27. PubMed ID: 19101522 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]